首页 > 最新文献

Mutagenesis最新文献

英文 中文
Matrine and Oxymatrine: evaluating the gene mutation potential using in silico tools and the bacterial reverse mutation assay (Ames test). 苦参碱和氧化苦参碱:利用硅工具和细菌反向突变试验(Ames试验)评估基因突变潜力。
IF 2.7 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2024-02-08 DOI: 10.1093/mutage/gead032
Benjamin Christian Fischer, Yemurai Musengi, Jeannette König, Benjamin Sachse, Stefanie Hessel-Pras, Bernd Schäfer, Carsten Kneuer, Kristin Herrmann

The quinolizidine alkaloids matrine and its N-oxide oxymatrine occur in plants of the genus Sophora. Recently, matrine was sporadically detected in liquorice products. Morphological similarity of the liquorice plant Glycyrrhiza glabra with Sophora species and resulting confusion during harvesting may explain this contamination, but use of matrine as pesticide has also been reported. The detection of matrine in liquorice products raised concern as some studies suggested a genotoxic activity of matrine and oxymatrine. However, these studies are fraught with uncertainties, putting the reliability and robustness into question. Another issue was that Sophora root extracts were usually tested instead of pure matrine and oxymatrine. The aim of this work was therefore to determine whether matrine and oxymatrine have potential for causing gene mutations. In a first step and to support a weight-of-evidence analysis, in silico predictions were performed to improve the database using expert and statistical systems by VEGA, Leadscope (Instem®), and Nexus (Lhasa Limited). Unfortunately, the confidence levels of the predictions were insufficient to either identify or exclude a mutagenic potential. Thus, in order to obtain reliable results, the bacterial reverse mutation assay (Ames test) was carried out in accordance with OECD Test Guideline 471. The test set included the plate incorporation and the preincubation assay. It was performed with five different bacterial strains in the presence or absence of metabolic activation. Neither matrine nor oxymatrine induced a significant increase in the number of revertants under any of the selected experimental conditions. Overall, it can be concluded that matrine and oxymatrine are unlikely to have a gene mutation potential. Any positive findings with Sophora extracts in the Ames test may be related to other components. Notably, the results also indicated a need to extend the application domain of respective (Q)SAR tools to secondary plant metabolites.

喹啉类生物碱苦参碱及其N-氧化氧化苦参碱存在于苦参属植物中。近年来,甘草制品中偶尔检出苦参碱。甘草植物光甘草(Glycyrhiza glabra)和苦参(Sophora)在形态上的相似性以及在收获过程中产生的混淆可能解释了这种污染,但也有报道称使用苦参碱作为农药。甘草制品中苦参碱的检测引起了人们的关注,因为一些研究表明苦参碱和氧化苦参碱具有遗传毒性活性。然而,这些研究充满了不确定性,使可靠性和稳健性受到质疑。另一个问题是,通常测试的是苦参根提取物,而不是纯苦参碱和氧化苦参碱。因此,这项工作的目的是确定苦参碱和氧化苦参碱是否具有引起基因突变的潜力。在第一步中,为了支持证据分析的权重,使用VEGA、Leadscope(Instem®)和Nexus(拉萨有限公司)的专家和统计系统进行了计算机预测,以改进数据库。不幸的是,预测的置信水平不足以识别或排除诱变潜力。因此,为了获得可靠的结果,根据OECD测试指南471进行细菌反向突变测定(Ames测试)。试验组包括平板掺入和预培养试验。在存在或不存在代谢活化的情况下,对五种不同的菌株进行了研究。在任何选定的实验条件下,苦参碱和氧化苦参碱都没有诱导回复子数量的显著增加。总之,可以得出结论,苦参碱和氧化苦参碱不太可能具有基因突变的潜力。艾姆斯试验中的任何Sophora提取物阳性结果都可能与其他成分有关。值得注意的是,研究结果还表明,需要将各自(Q)SAR工具的应用领域扩展到次生植物代谢物。
{"title":"Matrine and Oxymatrine: evaluating the gene mutation potential using in silico tools and the bacterial reverse mutation assay (Ames test).","authors":"Benjamin Christian Fischer, Yemurai Musengi, Jeannette König, Benjamin Sachse, Stefanie Hessel-Pras, Bernd Schäfer, Carsten Kneuer, Kristin Herrmann","doi":"10.1093/mutage/gead032","DOIUrl":"10.1093/mutage/gead032","url":null,"abstract":"<p><p>The quinolizidine alkaloids matrine and its N-oxide oxymatrine occur in plants of the genus Sophora. Recently, matrine was sporadically detected in liquorice products. Morphological similarity of the liquorice plant Glycyrrhiza glabra with Sophora species and resulting confusion during harvesting may explain this contamination, but use of matrine as pesticide has also been reported. The detection of matrine in liquorice products raised concern as some studies suggested a genotoxic activity of matrine and oxymatrine. However, these studies are fraught with uncertainties, putting the reliability and robustness into question. Another issue was that Sophora root extracts were usually tested instead of pure matrine and oxymatrine. The aim of this work was therefore to determine whether matrine and oxymatrine have potential for causing gene mutations. In a first step and to support a weight-of-evidence analysis, in silico predictions were performed to improve the database using expert and statistical systems by VEGA, Leadscope (Instem®), and Nexus (Lhasa Limited). Unfortunately, the confidence levels of the predictions were insufficient to either identify or exclude a mutagenic potential. Thus, in order to obtain reliable results, the bacterial reverse mutation assay (Ames test) was carried out in accordance with OECD Test Guideline 471. The test set included the plate incorporation and the preincubation assay. It was performed with five different bacterial strains in the presence or absence of metabolic activation. Neither matrine nor oxymatrine induced a significant increase in the number of revertants under any of the selected experimental conditions. Overall, it can be concluded that matrine and oxymatrine are unlikely to have a gene mutation potential. Any positive findings with Sophora extracts in the Ames test may be related to other components. Notably, the results also indicated a need to extend the application domain of respective (Q)SAR tools to secondary plant metabolites.</p>","PeriodicalId":18889,"journal":{"name":"Mutagenesis","volume":" ","pages":"32-42"},"PeriodicalIF":2.7,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10851102/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50158381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multi-endpoint analysis of cadmium chloride-induced genotoxicity shows role for reactive oxygen species and p53 activation in DNA damage induction, cell cycle irregularities, and cell size aberrations. 对氯化镉诱导的遗传毒性进行的多端点分析表明,活性氧和 p53 激活在 DNA 损伤诱导、细胞周期不规则和细胞大小畸变中发挥作用。
IF 2.7 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2024-02-08 DOI: 10.1093/mutage/gead025
Leanne M Stannard, Ann Doherty, Katherine E Chapman, Shareen H Doak, Gareth J Jenkins

Cadmium chloride (CdCl2) is a known genotoxic carcinogen, with a mechanism of action thought to partly involve the generation of reactive oxygen species (ROS). We applied here a multi-endpoint approach in vitro to explore the impact of CdCl2 on both the genome and on wider cell biology pathways relevant to cancer. Multi-endpoint approaches are believed to offer greater promise in terms of understanding the holistic effects of carcinogens in vitro. This richer understanding may help better classification of carcinogens as well as allowing detailed mechanisms of action to be identified. We found that CdCl2 caused DNA damage [micronuclei (MN)] in both TK6 and NH32 cells in a dose-dependent manner after 4 h exposure (plus 23 h recovery), with lowest observable effect levels (LOELs) for MN induction of 1 μM (TK6) and 1.6 μM (NH32). This DNA damage induction in TK6 cells was ROS dependent as pretreatment with the antioxidant N-Acetyl Cysteine (1 mM), abrogated this effect. However, 2',7'-dichlorofluorescin diacetate was not capable of detecting the ROS induced by CdCl2. The use of NH32 cells allowed an investigation of the role of p53 as they are a p53 null cell line derived from TK6. NH32 showed a 10-fold increase in MN in untreated cells and a similar dose-dependent effect after CdCl2 treatment. In TK6 cells, CdCl2 also caused activation of p53 (accumulation of total and phosphorylated p53), imposition of cell cycle checkpoints (G2/M) and intriguingly the production of smaller and more eccentric (elongated) cells. Overall, this multi-endpoint study suggests a carcinogenic mechanism of CdCl2 involving ROS generation, oxidative DNA damage and p53 activation, leading to cell cycle abnormalities and impacts of cell size and shape. This study shows how the integration of multiple cell biology endpoints studied in parallel in vitro can help mechanistic understanding of how carcinogens disrupt normal cell biology.

氯化镉(CdCl2)是一种已知的基因毒性致癌物质,其作用机制被认为部分涉及活性氧(ROS)的生成。在这里,我们采用体外多端点方法来探索氯化镉对基因组和与癌症相关的更广泛的细胞生物学通路的影响。多终端方法被认为在体外了解致癌物质的整体影响方面具有更大的前景。这种更丰富的理解可能有助于更好地对致癌物质进行分类,并确定详细的作用机制。我们发现,氯化镉在TK6和NH32细胞中造成DNA损伤[微核(MN)]的方式与暴露4小时(加23小时恢复期)的剂量有关,MN诱导的最低可观察效应水平(LOELs)分别为1 μM(TK6)和1.6 μM(NH32)。TK6 细胞的这种 DNA 损伤诱导作用依赖于 ROS,因为使用抗氧化剂 N-乙酰半胱氨酸(1 mM)进行预处理可减轻这种效应。然而,2',7'-二氯荧光素二乙酸酯无法检测到氯化镉诱导的 ROS。使用 NH32 细胞可以研究 p53 的作用,因为 NH32 是源自 TK6 的 p53 缺失细胞系。在未经处理的细胞中,NH32 的 MN 增加了 10 倍,而在氯化镉处理后也出现了类似的剂量依赖性效应。在 TK6 细胞中,氯化镉还会导致 p53 激活(总 p53 和磷酸化 p53 的积累)、细胞周期检查点的形成(G2/M),并产生更小、更偏心(拉长)的细胞。总之,这项多终端研究表明,氯化镉的致癌机制涉及 ROS 生成、DNA 氧化损伤和 p53 激活,从而导致细胞周期异常以及细胞大小和形状的影响。这项研究表明,整合体外平行研究的多个细胞生物学终点有助于从机理上理解致癌物质如何破坏正常的细胞生物学。
{"title":"Multi-endpoint analysis of cadmium chloride-induced genotoxicity shows role for reactive oxygen species and p53 activation in DNA damage induction, cell cycle irregularities, and cell size aberrations.","authors":"Leanne M Stannard, Ann Doherty, Katherine E Chapman, Shareen H Doak, Gareth J Jenkins","doi":"10.1093/mutage/gead025","DOIUrl":"10.1093/mutage/gead025","url":null,"abstract":"<p><p>Cadmium chloride (CdCl2) is a known genotoxic carcinogen, with a mechanism of action thought to partly involve the generation of reactive oxygen species (ROS). We applied here a multi-endpoint approach in vitro to explore the impact of CdCl2 on both the genome and on wider cell biology pathways relevant to cancer. Multi-endpoint approaches are believed to offer greater promise in terms of understanding the holistic effects of carcinogens in vitro. This richer understanding may help better classification of carcinogens as well as allowing detailed mechanisms of action to be identified. We found that CdCl2 caused DNA damage [micronuclei (MN)] in both TK6 and NH32 cells in a dose-dependent manner after 4 h exposure (plus 23 h recovery), with lowest observable effect levels (LOELs) for MN induction of 1 μM (TK6) and 1.6 μM (NH32). This DNA damage induction in TK6 cells was ROS dependent as pretreatment with the antioxidant N-Acetyl Cysteine (1 mM), abrogated this effect. However, 2',7'-dichlorofluorescin diacetate was not capable of detecting the ROS induced by CdCl2. The use of NH32 cells allowed an investigation of the role of p53 as they are a p53 null cell line derived from TK6. NH32 showed a 10-fold increase in MN in untreated cells and a similar dose-dependent effect after CdCl2 treatment. In TK6 cells, CdCl2 also caused activation of p53 (accumulation of total and phosphorylated p53), imposition of cell cycle checkpoints (G2/M) and intriguingly the production of smaller and more eccentric (elongated) cells. Overall, this multi-endpoint study suggests a carcinogenic mechanism of CdCl2 involving ROS generation, oxidative DNA damage and p53 activation, leading to cell cycle abnormalities and impacts of cell size and shape. This study shows how the integration of multiple cell biology endpoints studied in parallel in vitro can help mechanistic understanding of how carcinogens disrupt normal cell biology.</p>","PeriodicalId":18889,"journal":{"name":"Mutagenesis","volume":" ","pages":"13-23"},"PeriodicalIF":2.7,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10851103/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9960720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An integrated in vitro carcinogenicity test that distinguishes between genotoxic carcinogens, non-genotoxic carcinogens, and non-carcinogens 区分基因毒性致癌物、非基因毒性致癌物和非致癌物的综合体外致癌性试验
IF 2.7 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2024-02-01 DOI: 10.1093/mutage/geae004
Katherine E Chapman, Ume-Kulsoom Shah, Jessica F Fletcher, George E Johnson, Shareen H Doak, Gareth J S Jenkins
Chemical safety testing plays a crucial role in product and pharmacological development, as well as chemoprevention; however, in vitro genotoxicity safety tests do not always accurately predict the chemicals that will be in vivo carcinogens. If chemicals test positive in vitro for genotoxicity but negative in vivo, this can contribute to unnecessary testing in animals used to confirm erroneous in vitro positive results. Current in vitro tests typically evaluate only genotoxicity endpoints, which limits their potential to detect non-genotoxic carcinogens. The frequency of misleading in vitro positive results can be high, leading to a requirement for more informative in vitro tests. It is now recognised that multiple-endpoint genotoxicity testing may aid more accurate detection of carcinogens and non-carcinogens. The objective of this review was to evaluate the utility of our novel, multiple-endpoint in vitro test which uses multiple cancer-relevant endpoints to predict carcinogenic potential. The tool assessed micronucleus frequency, p53 expression, p21 expression, mitochondrial respiration, cell cycle abnormalities and, uniquely, cell morphology changes in human lymphoblastoid cell lines, TK6 and MCL-5. The endpoints were used to observe cellular responses to 18 chemicals within the following categories: genotoxic carcinogens, non-genotoxic carcinogens, toxic non-carcinogens, and misleading in vitro positive and negative agents. The number of endpoints significantly altered for each chemical was considered, alongside the holistic Integrated Signature of Carcinogenicity score, derived from the sum of fold changes for all endpoints. Following calculation of an overall score from these measures, carcinogens exhibited greater potency than non-carcinogens. Genotoxic carcinogens were generally more potent than non-genotoxic carcinogens. This novel approach therefore demonstrated potential for correctly predicting whether chemicals with unknown mechanism may be considered carcinogens. Overall, while further validation is recommended, the test demonstrates potential for identification of carcinogenic compounds. Adoption of the approach could enable reduced animal use in carcinogenicity testing.
化学品安全测试在产品和药物开发以及化学预防方面发挥着至关重要的作用;然而,体外遗传毒性安全测试并不总能准确预测体内致癌的化学品。如果化学品的体外基因毒性测试结果呈阳性,而体内测试结果呈阴性,就会造成不必要的动物试验,以确认错误的体外阳性结果。目前的体外测试通常只评估基因毒性终点,这限制了其检测非基因毒性致癌物的潜力。误导性体外阳性结果出现的频率可能很高,因此需要信息量更大的体外测试。现在人们认识到,多终点基因毒性测试有助于更准确地检测致癌物和非致癌物。本综述旨在评估我们的新型多终点体外测试的实用性,该测试使用多个癌症相关终点来预测致癌潜力。该工具评估了人类淋巴母细胞系 TK6 和 MCL-5 的微核频率、p53 表达、p21 表达、线粒体呼吸、细胞周期异常以及独特的细胞形态变化。这些终点用于观察细胞对以下类别中 18 种化学物质的反应:基因毒性致癌物、非基因毒性致癌物、毒性非致癌物以及误导性体外阳性和阴性制剂。在考虑每种化学品显著改变的终点数量的同时,还考虑了致癌综合特征得分,该得分由所有终点的折合变化总和得出。根据这些指标计算出总分后,致癌物质比非致癌物质表现出更强的效力。基因毒性致癌物通常比非基因毒性致癌物更强。因此,这种新方法在正确预测机制不明的化学品是否可能被视为致癌物方面显示出了潜力。总之,虽然建议进一步验证,但该测试显示了识别致癌化合物的潜力。采用这种方法可以减少致癌试验中动物的使用。
{"title":"An integrated in vitro carcinogenicity test that distinguishes between genotoxic carcinogens, non-genotoxic carcinogens, and non-carcinogens","authors":"Katherine E Chapman, Ume-Kulsoom Shah, Jessica F Fletcher, George E Johnson, Shareen H Doak, Gareth J S Jenkins","doi":"10.1093/mutage/geae004","DOIUrl":"https://doi.org/10.1093/mutage/geae004","url":null,"abstract":"Chemical safety testing plays a crucial role in product and pharmacological development, as well as chemoprevention; however, in vitro genotoxicity safety tests do not always accurately predict the chemicals that will be in vivo carcinogens. If chemicals test positive in vitro for genotoxicity but negative in vivo, this can contribute to unnecessary testing in animals used to confirm erroneous in vitro positive results. Current in vitro tests typically evaluate only genotoxicity endpoints, which limits their potential to detect non-genotoxic carcinogens. The frequency of misleading in vitro positive results can be high, leading to a requirement for more informative in vitro tests. It is now recognised that multiple-endpoint genotoxicity testing may aid more accurate detection of carcinogens and non-carcinogens. The objective of this review was to evaluate the utility of our novel, multiple-endpoint in vitro test which uses multiple cancer-relevant endpoints to predict carcinogenic potential. The tool assessed micronucleus frequency, p53 expression, p21 expression, mitochondrial respiration, cell cycle abnormalities and, uniquely, cell morphology changes in human lymphoblastoid cell lines, TK6 and MCL-5. The endpoints were used to observe cellular responses to 18 chemicals within the following categories: genotoxic carcinogens, non-genotoxic carcinogens, toxic non-carcinogens, and misleading in vitro positive and negative agents. The number of endpoints significantly altered for each chemical was considered, alongside the holistic Integrated Signature of Carcinogenicity score, derived from the sum of fold changes for all endpoints. Following calculation of an overall score from these measures, carcinogens exhibited greater potency than non-carcinogens. Genotoxic carcinogens were generally more potent than non-genotoxic carcinogens. This novel approach therefore demonstrated potential for correctly predicting whether chemicals with unknown mechanism may be considered carcinogens. Overall, while further validation is recommended, the test demonstrates potential for identification of carcinogenic compounds. Adoption of the approach could enable reduced animal use in carcinogenicity testing.","PeriodicalId":18889,"journal":{"name":"Mutagenesis","volume":"27 1","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139663858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tensin 1 regulated by hepatic leukemia factor represses the progression of prostate cancer. 受肝白血病因子调控的 Tensin 1 可抑制前列腺癌的进展。
IF 2.7 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2023-12-19 DOI: 10.1093/mutage/gead027
Hao Zhou, Fang Wang

Hepatic leukemia factor (HLF), a transcription factor, is dysregulated in many cancers. This study investigates the function of HLF in prostate cancer (PCa) and its relation to tensin 1 (TNS1). Clinical tissues were collected from 24 PCa patients. Duke University 145 (DU145) and PC3 cells overexpressing HLF were established. HLF signaling was downregulated in PCa tissues compared to adjacent tissues and in DU145 and PC3 cells compared to prostate epithelial cells RWPE-1 or prostate stromal cells (WPMY-1). PCa cell lines with overexpression of HLF had reduced proliferative, migratory, and invasive activity, increased apoptosis, and cell mitosis mostly in the G0/G1 phase. HLF induced the TNS1 transcription to activate the p53 pathway. Depletion of TNS1 reversed the anti-tumor effects of HLF on PCa cells and tumor growth and metastasis in vivo. In summary, our findings suggest that HLF suppressed PCa progression by upregulating TNS1 expression and inducing the p53 pathway activation, which might provide insights into novel strategies for combating PCa.

肝白血病因子(HLF)是一种转录因子,在许多癌症中都会发生失调。本研究探讨了肝白血病因子在前列腺癌(PCa)中的功能及其与田螺素1(TNS1)的关系。临床组织收集自 24 名 PCa 患者。建立了过表达 HLF 的杜克大学 145(DU145)和 PC3 细胞。与邻近组织相比,PCa 组织中的 HLF 信号下调;与前列腺上皮细胞 RWPE-1 或前列腺基质细胞(WPMY-1)相比,DU145 和 PC3 细胞中的 HLF 信号下调。过表达HLF的PCa细胞株的增殖、迁移和侵袭活性降低,凋亡增加,细胞有丝分裂大多处于G0/G1期。HLF诱导TNS1转录,激活p53通路。TNS1的缺失逆转了HLF对PCa细胞的抗肿瘤作用以及体内肿瘤的生长和转移。总之,我们的研究结果表明,HLF通过上调TNS1的表达和诱导p53通路活化来抑制PCa的进展,这可能会为抗击PCa的新策略提供启示。
{"title":"Tensin 1 regulated by hepatic leukemia factor represses the progression of prostate cancer.","authors":"Hao Zhou, Fang Wang","doi":"10.1093/mutage/gead027","DOIUrl":"10.1093/mutage/gead027","url":null,"abstract":"<p><p>Hepatic leukemia factor (HLF), a transcription factor, is dysregulated in many cancers. This study investigates the function of HLF in prostate cancer (PCa) and its relation to tensin 1 (TNS1). Clinical tissues were collected from 24 PCa patients. Duke University 145 (DU145) and PC3 cells overexpressing HLF were established. HLF signaling was downregulated in PCa tissues compared to adjacent tissues and in DU145 and PC3 cells compared to prostate epithelial cells RWPE-1 or prostate stromal cells (WPMY-1). PCa cell lines with overexpression of HLF had reduced proliferative, migratory, and invasive activity, increased apoptosis, and cell mitosis mostly in the G0/G1 phase. HLF induced the TNS1 transcription to activate the p53 pathway. Depletion of TNS1 reversed the anti-tumor effects of HLF on PCa cells and tumor growth and metastasis in vivo. In summary, our findings suggest that HLF suppressed PCa progression by upregulating TNS1 expression and inducing the p53 pathway activation, which might provide insights into novel strategies for combating PCa.</p>","PeriodicalId":18889,"journal":{"name":"Mutagenesis","volume":" ","pages":"295-304"},"PeriodicalIF":2.7,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10235416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of iron and calcium on radiation sensitivity in prostate cancer patients relative to controls. 与对照组相比,铁和钙对前列腺癌症患者辐射敏感性的影响。
IF 2.7 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2023-12-19 DOI: 10.1093/mutage/gead029
Varinderpal S Dhillon, Permal Deo, Michael Fenech

High intake of red meat and/or dairy products may increase the concentration of iron and calcium in plasma-a risk factor for prostate cancer (PC). Despite our understandings of nutrients and their effects on the genome, studies on the effects of iron and calcium on radiation sensitivity of PC patients are lacking. Therefore, we tested the hypothesis that high plasma levels of iron and calcium could increase baseline or radiation-induced DNA damage in PC patients relative to healthy controls. The present study was performed on 106 PC patients and 132 age-matched healthy individuals. CBMN assay was performed to measure mi-cronuclei (MN), nucleoplasmic bridges (NPBs), and nuclear buds (NBuds) in lymphocytes. Plasma concentrations of iron and calcium were measured using inductively coupled plasma atomic emission spectroscopy. MN, NPBs, and NBuds induced by radiation ex vivo were significantly higher in PC patients with high plasma iron (P = .004, P = .047, and P = .0003, respectively) compared to healthy controls. Radiation-induced MN and NBuds frequency were also significantly higher in PC patients (P = .001 and P = .0001, respectively) with high plasma calcium levels relative to controls. Furthermore, radiation-induced frequency of NBuds was significantly higher in PC patients (P < .0001) with high plasma levels of both iron and calcium relative to controls. Our results support the hypothesis that high iron and calcium levels in plasma increases the sensitivity to radiation-induced DNA damage and point to the need of developing nutrition-based strategies to minimize DNA damage in normal tissue of PC patients undergoing radiotherapy.

大量摄入红肉和/或乳制品可能会增加血浆中铁和钙的浓度,这是癌症(PC)的危险因素。尽管我们了解营养物质及其对基因组的影响,但缺乏关于铁和钙对PC患者辐射敏感性影响的研究。因此,我们检验了这样一种假设,即与健康对照组相比,高血浆铁和钙水平可能会增加PC患者的基线或辐射诱导的DNA损伤。本研究对106名PC患者和132名年龄匹配的健康人进行了研究。采用CBMN法测定淋巴细胞的微核(MN)、核质桥(NPBs)和核芽(NBuds)。使用电感耦合等离子体原子发射光谱法测量铁和钙的等离子体浓度。与健康对照组相比,具有高血浆铁的PC患者体内外辐射诱导的MN、NPBs和NBuds显著更高(分别为p=0.004、p=0.047和p=0.0003)。与对照组相比,血浆钙水平较高的PC患者的辐射诱导MN和NBuds频率也显著较高(分别为p=0.001和p=0.0001)。此外,与对照组相比,血浆铁和钙水平较高的PC患者的辐射诱导NBuds频率显著较高(p<0.0001)。我们的研究结果支持了血浆中高铁和钙水平增加了对辐射诱导的DNA损伤的敏感性的假设,并指出需要制定基于营养的策略,以最大限度地减少接受放疗的PC患者正常组织中的DNA损伤。
{"title":"Effect of iron and calcium on radiation sensitivity in prostate cancer patients relative to controls.","authors":"Varinderpal S Dhillon, Permal Deo, Michael Fenech","doi":"10.1093/mutage/gead029","DOIUrl":"10.1093/mutage/gead029","url":null,"abstract":"<p><p>High intake of red meat and/or dairy products may increase the concentration of iron and calcium in plasma-a risk factor for prostate cancer (PC). Despite our understandings of nutrients and their effects on the genome, studies on the effects of iron and calcium on radiation sensitivity of PC patients are lacking. Therefore, we tested the hypothesis that high plasma levels of iron and calcium could increase baseline or radiation-induced DNA damage in PC patients relative to healthy controls. The present study was performed on 106 PC patients and 132 age-matched healthy individuals. CBMN assay was performed to measure mi-cronuclei (MN), nucleoplasmic bridges (NPBs), and nuclear buds (NBuds) in lymphocytes. Plasma concentrations of iron and calcium were measured using inductively coupled plasma atomic emission spectroscopy. MN, NPBs, and NBuds induced by radiation ex vivo were significantly higher in PC patients with high plasma iron (P = .004, P = .047, and P = .0003, respectively) compared to healthy controls. Radiation-induced MN and NBuds frequency were also significantly higher in PC patients (P = .001 and P = .0001, respectively) with high plasma calcium levels relative to controls. Furthermore, radiation-induced frequency of NBuds was significantly higher in PC patients (P < .0001) with high plasma levels of both iron and calcium relative to controls. Our results support the hypothesis that high iron and calcium levels in plasma increases the sensitivity to radiation-induced DNA damage and point to the need of developing nutrition-based strategies to minimize DNA damage in normal tissue of PC patients undergoing radiotherapy.</p>","PeriodicalId":18889,"journal":{"name":"Mutagenesis","volume":" ","pages":"305-314"},"PeriodicalIF":2.7,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10728778/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41135604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhibition of homologous recombination repair by Mirin in ovarian cancer ameliorates carboplatin therapy response in vitro 用 Mirin 抑制卵巢癌的同源重组修复可改善体外卡铂治疗反应
IF 2.7 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2023-12-14 DOI: 10.1093/mutage/gead036
Josef Horak, Dominika Vallusova, Andrea Cumova, Petr Holy, Pavel Vodicka, Alena Opattova
Chemoresistance poses one of the most significant challenges of cancer therapy. Carboplatin (CbPt) is one of the most used chemotherapeutics in ovarian cancer (OVC) treatment. MRE11 constitutes a part of homologous recombination (HR), which is responsible for the repair of CbPt-induced DNA damage, particularly DNA crosslinks. The study’s main aim was to address the role of HR in CbPt chemoresistance in OVC and to evaluate the possibility of overcoming CbPt chemoresistance by Mirin-mediated MRE11 inhibition in an OVC cell line. Lower expression of MRE11 was associated with better overall survival in a cohort of OVC patients treated with platinum drugs (TCGA dataset, p &lt; 0.05). Using in vitro analyses, we showed that the high expression of HR genes drives the CbPt chemoresistance in our CbPt-resistant cell line model. Moreover, the HR inhibition by Mirin not only increased sensitivity to carboplatin (p &lt; 0.05) but also rescued the sensitivity in the CbPt-resistant model (p &lt; 0.05). Our results suggest that MRE11 inhibition with Mirin may represent a promising way to overcome OVC resistance. More therapy options will ultimately lead to better personalized cancer therapy and improvement of patients’ survival.
化疗耐药性是癌症治疗面临的最大挑战之一。卡铂(CbPt)是卵巢癌(OVC)治疗中最常用的化疗药物之一。MRE11是同源重组(HR)的一部分,负责修复卡铂诱导的DNA损伤,尤其是DNA交联。该研究的主要目的是探讨HR在OVC的CbPt化疗耐药性中的作用,并评估在OVC细胞系中通过Mirin介导的MRE11抑制克服CbPt化疗耐药性的可能性。在一组接受铂类药物治疗的OVC患者中,MRE11的较低表达与较好的总生存率相关(TCGA数据集,p &lt; 0.05)。通过体外分析,我们发现在我们的 CbPt 耐药细胞系模型中,HR 基因的高表达驱动了 CbPt 的化疗耐药性。此外,Mirin抑制HR不仅提高了对卡铂的敏感性(p&p;lt; 0.05),还挽救了CbPt耐药模型的敏感性(p&p;lt; 0.05)。我们的研究结果表明,用Mirin抑制MRE11可能是克服OVC耐药性的一种很有前景的方法。更多的治疗选择最终将带来更好的个性化癌症治疗,并改善患者的生存状况。
{"title":"Inhibition of homologous recombination repair by Mirin in ovarian cancer ameliorates carboplatin therapy response in vitro","authors":"Josef Horak, Dominika Vallusova, Andrea Cumova, Petr Holy, Pavel Vodicka, Alena Opattova","doi":"10.1093/mutage/gead036","DOIUrl":"https://doi.org/10.1093/mutage/gead036","url":null,"abstract":"Chemoresistance poses one of the most significant challenges of cancer therapy. Carboplatin (CbPt) is one of the most used chemotherapeutics in ovarian cancer (OVC) treatment. MRE11 constitutes a part of homologous recombination (HR), which is responsible for the repair of CbPt-induced DNA damage, particularly DNA crosslinks. The study’s main aim was to address the role of HR in CbPt chemoresistance in OVC and to evaluate the possibility of overcoming CbPt chemoresistance by Mirin-mediated MRE11 inhibition in an OVC cell line. Lower expression of MRE11 was associated with better overall survival in a cohort of OVC patients treated with platinum drugs (TCGA dataset, p &amp;lt; 0.05). Using in vitro analyses, we showed that the high expression of HR genes drives the CbPt chemoresistance in our CbPt-resistant cell line model. Moreover, the HR inhibition by Mirin not only increased sensitivity to carboplatin (p &amp;lt; 0.05) but also rescued the sensitivity in the CbPt-resistant model (p &amp;lt; 0.05). Our results suggest that MRE11 inhibition with Mirin may represent a promising way to overcome OVC resistance. More therapy options will ultimately lead to better personalized cancer therapy and improvement of patients’ survival.","PeriodicalId":18889,"journal":{"name":"Mutagenesis","volume":"5 1","pages":""},"PeriodicalIF":2.7,"publicationDate":"2023-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138684991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long or short? Telomere length and pancreatic cancer and its precursor lesions, a narrative review. 长还是短?端粒长度与胰腺癌及其前体病变的关系。
IF 2.7 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2023-11-17 DOI: 10.1093/mutage/gead034
Daniele Campa, Alessio Felici, Chiara Corradi, Giulia Peduzzi, Manuel Gentiluomo, Riccardo Farinella, Cosmeri Rizzato

Pancreatic ductal adenocarcinoma (PDAC) is the most common and lethal form of pancreatic cancer, with a survival approaching only 11% at five years after diagnosis. In the last 15 years, telomere length measured in leukocyte (LTL) has been studied in relation to PDAC risk. The majority of the studies reported an association between short LTL and increased PDAC risk, but the results are heterogeneous. Genome-wide association studies have identified several single nucleotide polymorphisms (SNPs) in the telomerase reverse transcriptase (TERT) gene as susceptibility loci for PDAC. Polygenic risk scores (PRS) computed using SNPs associated with LTL have been tested in relation to PDAC susceptibility with various methods and giving contrasting results. The aim of this review is to analyze all publications carried out specifically on LTL, considering LTL measured with qPCR and with genetic proxies, and PDAC risk. Additionally, we will give an overview of the most relevant associations between SNPs in telomere associated genes and PDAC, to answer the question shorter or longer? Which one of the two is associated with PDAC risk?

胰腺导管腺癌(PDAC)是最常见和最致命的胰腺癌,诊断后5年生存率接近11%。在过去的15年中,端粒长度在白细胞(LTL)测量已研究与PDAC风险。大多数研究报告了较短的LTL与PDAC风险增加之间的关联,但结果是不一致的。全基因组关联研究已经确定端粒酶逆转录酶(TERT)基因中的几个单核苷酸多态性(snp)是PDAC的易感位点。使用与LTL相关的snp计算的多基因风险评分(PRS)已经用各种方法测试了与PDAC易感性的关系,并给出了对比的结果。本综述的目的是分析所有专门针对LTL的出版物,考虑到用qPCR和遗传代理测量的LTL,以及PDAC风险。此外,我们将概述端粒相关基因中snp与PDAC之间最相关的关联,以回答短或长?两者中哪一个与PDAC风险相关?
{"title":"Long or short? Telomere length and pancreatic cancer and its precursor lesions, a narrative review.","authors":"Daniele Campa, Alessio Felici, Chiara Corradi, Giulia Peduzzi, Manuel Gentiluomo, Riccardo Farinella, Cosmeri Rizzato","doi":"10.1093/mutage/gead034","DOIUrl":"https://doi.org/10.1093/mutage/gead034","url":null,"abstract":"<p><p>Pancreatic ductal adenocarcinoma (PDAC) is the most common and lethal form of pancreatic cancer, with a survival approaching only 11% at five years after diagnosis. In the last 15 years, telomere length measured in leukocyte (LTL) has been studied in relation to PDAC risk. The majority of the studies reported an association between short LTL and increased PDAC risk, but the results are heterogeneous. Genome-wide association studies have identified several single nucleotide polymorphisms (SNPs) in the telomerase reverse transcriptase (TERT) gene as susceptibility loci for PDAC. Polygenic risk scores (PRS) computed using SNPs associated with LTL have been tested in relation to PDAC susceptibility with various methods and giving contrasting results. The aim of this review is to analyze all publications carried out specifically on LTL, considering LTL measured with qPCR and with genetic proxies, and PDAC risk. Additionally, we will give an overview of the most relevant associations between SNPs in telomere associated genes and PDAC, to answer the question shorter or longer? Which one of the two is associated with PDAC risk?</p>","PeriodicalId":18889,"journal":{"name":"Mutagenesis","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2023-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136398280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstracts of the 45th Annual Meeting of the United Kingdom Environmental Mutagen Society, 2nd – 5th July 2023 at Clontarf Castle Hotel, Dublin, Ireland 第45届英国环境诱变剂协会年会,2023年7月2日至5日在爱尔兰都柏林的Clontarf城堡酒店举行
4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2023-11-14 DOI: 10.1093/mutage/gead024
{"title":"Abstracts of the 45th Annual Meeting of the United Kingdom Environmental Mutagen Society, 2nd – 5th July 2023 at Clontarf Castle Hotel, Dublin, Ireland","authors":"","doi":"10.1093/mutage/gead024","DOIUrl":"https://doi.org/10.1093/mutage/gead024","url":null,"abstract":"","PeriodicalId":18889,"journal":{"name":"Mutagenesis","volume":"114 15","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134957330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Visual comet scoring revisited: a guide to scoring comet assay slides and obtaining reliable results. 再次访问视觉彗星评分:彗星分析幻灯片评分和获得可靠结果的指南。
IF 2.7 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2023-10-14 DOI: 10.1093/mutage/gead015
Peter Møller, Amaya Azqueta, Julen Sanz-Serrano, Tamara Bakuradze, Elke Richling, Ezgi Eyluel Bankoglu, Helga Stopper, Victoria Claudino Bastos, Sabine A S Langie, Annie Jensen, Francesca Scavone, Lisa Giovannelli, Maria Wojewódzka, Marcin Kruszewski, Vanessa Valdiglesias, Blanca Laffon, Carla Costa, Solange Costa, João Paulo Teixeira, Mirko Marino, Cristian Del Bo, Patrizia Riso, Congying Zheng, Sergey Shaposhnikov, Andrew Collins

Measurement of DNA migration in the comet assay can be done by image analysis or visual scoring. The latter accounts for 20%-25% of the published comet assay results. Here we assess the intra- and inter-investigator variability in visual scoring of comets. We include three training sets of comet images, which can be used as reference for researchers who wish to use visual scoring of comets. Investigators in 11 different laboratories scored the comet images using a five-class scoring system. There is inter-investigator variation in the three training sets of comets (i.e. coefficient of variation (CV) = 9.7%, 19.8%, and 15.2% in training sets I-III, respectively). However, there is also a positive correlation of inter-investigator scoring in the three training sets (r = 0.60). Overall, 36% of the variation is attributed to inter-investigator variation and 64% stems from intra-investigator variation in scoring between comets (i.e. the comets in training sets I-III look slightly different and this gives rise to heterogeneity in scoring). Intra-investigator variation in scoring was also assessed by repeated analysis of the training sets by the same investigator. There was larger variation when the training sets were scored over a period of six months (CV = 5.9%-9.6%) as compared to 1 week (CV = 1.3%-6.1%). A subsequent study revealed a high inter-investigator variation when premade slides, prepared in a central laboratory, were stained and scored by investigators in different laboratories (CV = 105% and 18%-20% in premade slides with comets from unexposed and hydrogen peroxide-exposed cells, respectively). The results indicate that further standardization of visual scoring is desirable. Nevertheless, the analysis demonstrates that visual scoring is a reliable way of analysing DNA migration in comets.

彗星测定中DNA迁移的测量可以通过图像分析或视觉评分来完成。后者占已公布彗星测定结果的20%-25%。在这里,我们评估了彗星视觉评分中研究人员内部和内部的可变性。我们包括三组彗星图像的训练集,可供希望使用彗星视觉评分的研究人员参考。11个不同实验室的研究人员使用五级评分系统对彗星图像进行评分。彗星的三个训练集存在研究者之间的差异(即,i-III训练集的变异系数(CV)分别为9.7%、19.8%和15.2%)。然而,在三个训练集中,研究者之间的得分也存在正相关(r=0.60)。总体而言,36%的变化归因于研究者间的差异,64%的变化源于彗星之间得分的研究者内部差异(即训练集中i-III的彗星看起来略有不同,这导致了得分的异质性)。研究者内部评分的变化也通过同一研究者对训练集的重复分析进行评估。与1周(CV=1.3%-6.1%)相比,在6个月内对训练集进行评分时,差异更大(CV=5.9%-9.6%)。随后的一项研究显示,在中央实验室准备的预制幻灯片,由不同实验室的研究人员进行染色和评分(在未暴露和过氧化氢暴露细胞的彗星预制载玻片中,CV分别为105%和18%-20%)。结果表明,视觉评分的进一步标准化是可取的。然而,分析表明,视觉评分是分析彗星DNA迁移的可靠方法。
{"title":"Visual comet scoring revisited: a guide to scoring comet assay slides and obtaining reliable results.","authors":"Peter Møller,&nbsp;Amaya Azqueta,&nbsp;Julen Sanz-Serrano,&nbsp;Tamara Bakuradze,&nbsp;Elke Richling,&nbsp;Ezgi Eyluel Bankoglu,&nbsp;Helga Stopper,&nbsp;Victoria Claudino Bastos,&nbsp;Sabine A S Langie,&nbsp;Annie Jensen,&nbsp;Francesca Scavone,&nbsp;Lisa Giovannelli,&nbsp;Maria Wojewódzka,&nbsp;Marcin Kruszewski,&nbsp;Vanessa Valdiglesias,&nbsp;Blanca Laffon,&nbsp;Carla Costa,&nbsp;Solange Costa,&nbsp;João Paulo Teixeira,&nbsp;Mirko Marino,&nbsp;Cristian Del Bo,&nbsp;Patrizia Riso,&nbsp;Congying Zheng,&nbsp;Sergey Shaposhnikov,&nbsp;Andrew Collins","doi":"10.1093/mutage/gead015","DOIUrl":"10.1093/mutage/gead015","url":null,"abstract":"<p><p>Measurement of DNA migration in the comet assay can be done by image analysis or visual scoring. The latter accounts for 20%-25% of the published comet assay results. Here we assess the intra- and inter-investigator variability in visual scoring of comets. We include three training sets of comet images, which can be used as reference for researchers who wish to use visual scoring of comets. Investigators in 11 different laboratories scored the comet images using a five-class scoring system. There is inter-investigator variation in the three training sets of comets (i.e. coefficient of variation (CV) = 9.7%, 19.8%, and 15.2% in training sets I-III, respectively). However, there is also a positive correlation of inter-investigator scoring in the three training sets (r = 0.60). Overall, 36% of the variation is attributed to inter-investigator variation and 64% stems from intra-investigator variation in scoring between comets (i.e. the comets in training sets I-III look slightly different and this gives rise to heterogeneity in scoring). Intra-investigator variation in scoring was also assessed by repeated analysis of the training sets by the same investigator. There was larger variation when the training sets were scored over a period of six months (CV = 5.9%-9.6%) as compared to 1 week (CV = 1.3%-6.1%). A subsequent study revealed a high inter-investigator variation when premade slides, prepared in a central laboratory, were stained and scored by investigators in different laboratories (CV = 105% and 18%-20% in premade slides with comets from unexposed and hydrogen peroxide-exposed cells, respectively). The results indicate that further standardization of visual scoring is desirable. Nevertheless, the analysis demonstrates that visual scoring is a reliable way of analysing DNA migration in comets.</p>","PeriodicalId":18889,"journal":{"name":"Mutagenesis","volume":" ","pages":"253-263"},"PeriodicalIF":2.7,"publicationDate":"2023-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9876699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Long-term cryopreservation of potassium bromate positive assay controls for measurement of oxidatively damaged DNA by the Fpg-modified comet assay: results from the hCOMET ring trial. 溴酸钾阳性测定对照的长期冷冻保存,通过Fpg修饰的彗星测定法测量氧化损伤的DNA:来自hCOMET环试验的结果。
IF 2.7 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2023-10-14 DOI: 10.1093/mutage/gead020
Peter Møller, Amaya Azqueta, Adriana Rodriguez-Garraus, Tamara Bakuradze, Elke Richling, Ezgi Eyluel Bankoglu, Helga Stopper, Victoria Claudino Bastos, Sabine A S Langie, Annie Jensen, Sara Ristori, Francesca Scavone, Lisa Giovannelli, Maria Wojewódzka, Marcin Kruszewski, Vanessa Valdiglesias, Blanca Laffon, Carla Costa, Solange Costa, João Paulo Teixeira, Mirko Marino, Cristian Del Bo', Patrizia Riso, Congying Zheng, Sergey Shaposhnikov, Andrew Collins

The formamidopyrimidine DNA glycosylase (Fpg)-modified comet assay is widely used for the measurement of oxidatively generated damage to DNA. However, there has not been a recommended long-term positive control for this version of the comet assay. We have investigated potassium bromate as a positive control for the Fpg-modified comet assay because it generates many Fpg-sensitive sites with a little concurrent generation of DNA strand breaks. Eight laboratories used the same procedure for the treatment of monocytic THP-1 cells with potassium bromate (0, 0.5, 1.5, and 4.5 mM) and subsequent cryopreservation in a freezing medium consisting of 50% foetal bovine serum, 40% RPMI-1640 medium, and 10% dimethyl sulphoxide. The samples were analysed by the Fpg-modified comet assay three times over a 3-year period. All laboratories obtained a positive concentration-response relationship in cryopreserved samples (linear regression coefficients ranging from 0.79 to 0.99). However, there was a wide difference in the levels of Fpg-sensitive sites between the laboratory with the lowest (4.2% Tail DNA) and highest (74% Tail DNA) values in THP-1 cells after exposure to 4.5 mM KBrO3. In an attempt to assess sources of inter-laboratory variation in Fpg-sensitive sites, comet images from one experiment in each laboratory were forwarded to a central laboratory for visual scoring. There was high consistency between measurements of %Tail DNA values in each laboratory and the visual score of the same comets done in the central laboratory (r = 0.98, P < 0.001, linear regression). In conclusion, the results show that potassium bromate is a suitable positive comet assay control.

甲酰胺嘧啶DNA糖基化酶(Fpg)修饰的彗星试验被广泛用于测量DNA氧化损伤。然而,目前还没有推荐这种彗星试验的长期阳性对照。我们研究了溴酸钾作为Fpg修饰彗星测定的阳性对照,因为它产生了许多Fpg敏感位点,同时产生了少量DNA链断裂。八个实验室使用相同的程序用溴酸钾(0、0.5、1.5和4.5mM)处理单核细胞THP-1细胞,随后在由50%胎牛血清、40%RPMI-1640培养基和10%二甲基亚砜组成的冷冻培养基中冷冻保存。在3年的时间里,通过Fpg改良彗星试验对样本进行了三次分析。所有实验室在冷冻保存的样品中都获得了正浓度-反应关系(线性回归系数在0.79至0.99之间)。然而,暴露于4.5mM KBrO3后,THP-1细胞中Fpg敏感位点的水平在THP-1细胞的最低值(4.2%Tail DNA)和最高值(74%Tail脱氧核糖核酸)的实验室之间存在很大差异。为了评估Fpg敏感地点实验室间变化的来源,将每个实验室一个实验的彗星图像转发给中央实验室进行视觉评分。每个实验室对%尾DNA值的测量与中央实验室对相同彗星的视觉评分之间存在高度一致性(r=0.98,P<0.001,线性回归)。总之,结果表明溴酸钾是一种合适的彗星试验阳性对照。
{"title":"Long-term cryopreservation of potassium bromate positive assay controls for measurement of oxidatively damaged DNA by the Fpg-modified comet assay: results from the hCOMET ring trial.","authors":"Peter Møller,&nbsp;Amaya Azqueta,&nbsp;Adriana Rodriguez-Garraus,&nbsp;Tamara Bakuradze,&nbsp;Elke Richling,&nbsp;Ezgi Eyluel Bankoglu,&nbsp;Helga Stopper,&nbsp;Victoria Claudino Bastos,&nbsp;Sabine A S Langie,&nbsp;Annie Jensen,&nbsp;Sara Ristori,&nbsp;Francesca Scavone,&nbsp;Lisa Giovannelli,&nbsp;Maria Wojewódzka,&nbsp;Marcin Kruszewski,&nbsp;Vanessa Valdiglesias,&nbsp;Blanca Laffon,&nbsp;Carla Costa,&nbsp;Solange Costa,&nbsp;João Paulo Teixeira,&nbsp;Mirko Marino,&nbsp;Cristian Del Bo',&nbsp;Patrizia Riso,&nbsp;Congying Zheng,&nbsp;Sergey Shaposhnikov,&nbsp;Andrew Collins","doi":"10.1093/mutage/gead020","DOIUrl":"10.1093/mutage/gead020","url":null,"abstract":"<p><p>The formamidopyrimidine DNA glycosylase (Fpg)-modified comet assay is widely used for the measurement of oxidatively generated damage to DNA. However, there has not been a recommended long-term positive control for this version of the comet assay. We have investigated potassium bromate as a positive control for the Fpg-modified comet assay because it generates many Fpg-sensitive sites with a little concurrent generation of DNA strand breaks. Eight laboratories used the same procedure for the treatment of monocytic THP-1 cells with potassium bromate (0, 0.5, 1.5, and 4.5 mM) and subsequent cryopreservation in a freezing medium consisting of 50% foetal bovine serum, 40% RPMI-1640 medium, and 10% dimethyl sulphoxide. The samples were analysed by the Fpg-modified comet assay three times over a 3-year period. All laboratories obtained a positive concentration-response relationship in cryopreserved samples (linear regression coefficients ranging from 0.79 to 0.99). However, there was a wide difference in the levels of Fpg-sensitive sites between the laboratory with the lowest (4.2% Tail DNA) and highest (74% Tail DNA) values in THP-1 cells after exposure to 4.5 mM KBrO3. In an attempt to assess sources of inter-laboratory variation in Fpg-sensitive sites, comet images from one experiment in each laboratory were forwarded to a central laboratory for visual scoring. There was high consistency between measurements of %Tail DNA values in each laboratory and the visual score of the same comets done in the central laboratory (r = 0.98, P < 0.001, linear regression). In conclusion, the results show that potassium bromate is a suitable positive comet assay control.</p>","PeriodicalId":18889,"journal":{"name":"Mutagenesis","volume":" ","pages":"264-272"},"PeriodicalIF":2.7,"publicationDate":"2023-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10042290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Mutagenesis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1